Rossari Biotech to acquire Tristar Intermediates for INR120 crore

Rossari Biotech Limited announced the acquisition of 100% equity of Tristar Intermediates Pvt. Ltd. for an enterprise value of INR120 crore. The deal includes 76% upfront and 24% over three years, funded from cash on balance sheet.

“Rossari Biotech Limited today announced that its Board of Directors has approved the acquisition of Tristar Intermediates Pvt. Ltd.”rossari.com

• 2 sources
• rossari.comRossari to acquire Tristar Intermediates - Rossari Biotech LimitedrossariJul 17, 2021
• business-standard.comRossari to acquire Tristar Intermediates at enterprise value of Rs 120 cr | Company News - Business StandardPress Trust of IndiaJul 18, 2021

Summarized from public sources; check the original articles before acting on it.